The Journal of Organic Chemistry
Article
1.5 equiv) to afford product 5b which crystallized into white flakes
from toluene (0.17 g, 81%). Mp =108.8−109.3 °C. H NMR: δ 8.73
0.94 (3H). 13C NMR: δ 163.1, 148.6, 147.9, 133.3, 131.1, 127.3, 119.3,
79.4, 44.7, 40.4, 37.1, 27.5, 26.6, 24.2, 22.1, 21.8. IR νmax: 2912, 1724,
1529, 1349, 1295, 732 cm−1. HRMS (ESI): calcd C16H18N2O6 [M +
Na]+ 357.10571, found [M + Na]+ 357.10593.
1
(1H, s), 8.16 (1H, d, J = 7.3 Hz), 7.93 (3H, m), 7.63 (1H, t, J = 7.3
Hz), 7.56 (1H, t, J = 7.3 Hz), 5.68 (1H, ddd, J = 9.2, 2.4, 2.4 Hz),
2.40−1.75 (7H, m), 1.25 (3H, s), 1.14 (3H, s), 1.04 (1H, d, J = 10.2
Hz). 13C NMR: δ 165.9, 135.9, 132.5, 130.6, 129.1, 128.5, 127.8,
127.5, 126.8, 126.3, 125.0, 76.1, 45.2, 40.6, 37.3, 27.4, 26.9, 24.3, 22.9,
22.8. IR νmax: 2918, 1708, 1276, 777, 761 cm−1. HRMS (ESI): calcd
C20H22O2 [M + Na]+ 317.15120, found [M + Na]+ 317.15125.
α-Nopinyl 3-Nitrobenzoate (5c). Following general procedure B, α-
nopinol (5) (0.1 g, 0.71 mmol) in anhydrous Et2O (1 mL) and
pyridine was treated with 3-nitrobenzoyl chloride (0.14 g, 0.75 mmol)
for 2 h to afford product 5c as a yellow solid (0.16 g, 76%). Mp =
80.1−80.5 °C. 1H NMR: δ 8.84 (1H, s), 8.40 (1H, dd, J = 8.0, 2.3 Hz),
8.35 (1H, d, J = 8.0 Hz), 7.65 (1H, t, J = 8.0 Hz), 5.56 (1H, ddd, J =
9.8, 3.3, 3.3 Hz), 2.51−1.78 (7H, m), 1.26 (3H, s), 1.19 (3H, s,), 1.11
(1H, d, J = 10.3 Hz). 13C NMR: δ 163.4, 147.9, 134.7, 132.4, 129.3,
β-Nopinyl 4-Nitrophenoxide (6a). Following general procedure A,
potassium hydride (0.03 g, 0.71 mmol) was added to β-nopinol (6)
(0.1 g, 0.71 mmol) in anhydrous THF (2 mL). 4-Fluoronitrobenzene
(0.08 g, 0.75 mmol) was then added to this mixture and stirred for 2 h
to afford product 6a which crystallized into brown rectangular blocks
from DCM (0.15 g, 81%). Mp = 75.2−77.0 °C. 1H NMR: δ 8.14 (2H,
d, J = 9.4 Hz), 6.87 (2H, d, J = 9.4 Hz), 4.82 (1H, ddd, J = 6.93, 6.93,
1.8 Hz), 2.26−1.78 (7H, m), 1.62 (1H, d, J = 9.6 Hz), 1.28 (3H, s),
0.93 (3H, s). 13C NMR: δ 163.3, 140.9, 125.8, 115.2, 77.1, 44.4, 40.2,
39.2, 29.6, 26.4, 23.2, 22.8, 20.1. IR νmax: 2917, 1590, 1495, 1300, 1266
cm−1. HRMS (ESI): calcd C15H19NO3 [M + H]+ 262.14377, found
[M + H]+ 262.14377.
β-Nopinyl 2-Naphthoate (6b). Following general procedure B, β-
nopinol (6) (0.1 g, 0.71 mmol) in anhydrous DCM (1 mL) and
pyridine was treated with 2-naphthoyl chloride (0.142 g, 1.75 mmol,
1.5 equiv) to afford product 6b which crystallized into white flakes
126.7, 124.0, 77.0, 44.9, 40.4, 37.2, 27.1, 26.6, 24.1, 22.6, 22.5. IR νmax
:
2921, 1714, 1536, 1346, 1294, 1259, 717 cm−1. HRMS (ESI): calcd
C16H19NO4 [M + Na]+ 312.12063, found [M + Na]+ 312.12083.
α-Nopinyl 4-Nitrobenzoate (5d). Following general procedure B,
α-nopinol (5) (0.1 g, 0.71 mmol) in anhydrous Et2O (1 mL) and
pyridine was treated with 4-nitrobenzoyl chloride (0.14 g, 0.75 mmol)
for 2 h to afford product 5d as yellow solid (0.15 g, 73%). Mp = 80.1−
80.5 °C. 1H NMR: δ 8.29 (2H, d, J = 8.8 Hz), 8.19 (2H, d, J = 8.8 Hz),
5.55 (1H, ddd, J = 9.8, 3.6, 3.3 Hz), 2.51−1.78 (7H, m), 1.26 (3H, s),
1.17 (3H, s), 1.11 (1H, d, J = 10.3 Hz). 13C NMR: δ 164.0, 150.3,
136.3, 130.5, 123.4, 77.4, 45.2, 40.6, 37.4, 27.4, 26.9, 24.3, 22.9, 22.7.
IR νmax: 2924, 1712, 1523, 1345, 1288, 717 cm−1. HRMS (ESI): calcd
C16H19NO4 [M + H]+ 290.13868, found [M + H]+ 290.13871.
α-Nopinyl 3,5-Dinitrobenzoate (5e). Following general procedure
B, α-nopinol (5) (0.1 g, 0.71 mmol) in anhydrous Et2O (1 mL) and
pyridine was treated with 3,5-dinitrobenzoyl chloride (0.17 g, 0.75
mmol) for 2 h to afford product 5e as a yellow solid (0.19 g, 80%). Mp
= 100.0−101.8 °C. 1H NMR: δ 9.21 (1H, d, J = 2.1 Hz), 9.14 (2H, d, J
= 2.1 Hz), 5.62 (1H, ddd, J = 10.0, 3.5, 3.3 Hz), 2.52−1.81 (7H, m),
1.28 (3H, s), 1.20 (3H, s), 1.13 (1H, d, J = 10.3 Hz). 13C NMR: δ
161.9, 148.5, 134.6, 129.2, 122.0, 78.7, 45.1, 40.6, 37.5, 27.3, 26.8, 24.2,
22.9, 22.6. IR νmax: 2923, 1719, 1541, 1344, 1286, 719 cm−1. HRMS
(ESI): calcd C16H18N2O6 [M + Na]+ 357.10571, found [M + Na]+
357.10598.
1
from toluene (0.16 g, 76%). Mp = 88.9−90.4 °C. H NMR: δ 8.60
(1H, s), 8.08 (1H, d, J = 10.8 Hz), 7.95 (1H, d, J = 8.0 Hz), 7.85 (2H,
d, J = 8.4 Hz), 7.55 (2H, m), 5.54 (1H, bt, J = 7.6 Hz), 2.44−1.82 (7H,
m), 1.74 (1H, d, J = 8.8 Hz), 1.31 (3H, s), 0.97 (3H, s). 13C NMR: δ
166.2, 135.3, 132.3, 130.6, 129.1, 128.6, 127.9, 127.8, 127.6, 126.3,
125.1, 74.4, 45.0, 40.2, 39.4, 26.3, 23.3, 23.2, 22.3, 20.0. IR νmax: 2922,
1705, 1277, 779, 762 cm−1. HRMS (ESI): calcd C20H22O2 [M + H]+
295.16926, found [M + H]+ 295.16935.
β-Nopinyl 3-Nitrobenzoate (6c). Following general procedure B, β-
nopinol (6) (0.1 g, 0.71 mmol) in anhydrous Et2O (1 mL) and
pyridine was treated with 3-nitrobenzoyl chloride (0.14 g, 0.75 mmol)
for 2 h to afford product 6c as a yellow solid (0.18 g, 87%). Mp =
1
70.0−71.0 °C. H NMR: δ 8.65 (1H, d, J = 1.6 Hz), 8.28 (1H, d, J =
7.9 Hz), 8.25 (1H, t, J = 7.9 Hz), 7.57 (1H, t, J = 7.9 Hz), 5.37 (1H, br
t, J = 6.7, 6.1, 1.5 Hz), 2.26−1.71 (7H, m), 1.58 (1H, d, J = 10.3 Hz),
1.19 (3H), 0.84 (3H, s). 13C NMR: δ 163.7, 147.9, 134.9, 132.4, 129.3,
126.8, 124.0, 75.5, 44.7, 40.0, 39.3, 26.2, 23.1, 23.0, 22.0, 19.9. IR νmax
:
2927, 1716, 1524, 1347, 1264, 717 cm−1. HRMS (ESI): calcd
C16H19NO4 [M + Na]+ 312.12063, found [M + Na]+ 312.12073.
β-Nopinyl 4-Nitrobenzoate (6d). Following general procedure B,
β-nopinol (6) (0.1 g, 0.71 mmol) in anhydrous Et2O (1 mL) and
pyridine was treated with 4-nitrobenzoyl chloride (0.14 g, 0.75 mmol)
for 2 h to afford product 6d as a yellow solid (0.18 g, 87%). Mp =
104.3−106.0 °C. 1H NMR: δ 8.26 (2H, d, J = 8.9 Hz), 8.18 (2H, d, J =
8.9), 5.47 (1H, m), 2.34−1.77 (7H, m), 1.64 (1H, d, J = 9.6 Hz), 1.28
(3H, s), 0.94 (3H). 13C NMR: δ 164.1, 150.2, 136.2, 130.4, 123.3,
75.7, 44.9, 40.2, 39.5, 26.3, 23.2, 23.1, 22.2, 20.0. IR νmax: 2919, 1710,
1522, 1346, 1285, 716 cm−1. HRMS (ESI): calcd C16H19NO4 [M +
Na]+ 312.12063, found [M + Na]+ 312.12077.
α-Nopinyl 3,4-Dinitrobenzoate (5f). Following general procedure
B, α-nopinol (5) (0.1 g, 0.71 mmol) in anhydrous Et2O (1 mL) and
pyridine was treated with 3,4-dinitrobenzoyl chloride (0.17 g, 0.75
mmol) for 2 h to afford product 5f as yellow solid (0.19 g, 76%). Mp =
122.0−123.3 °C. 1H NMR: δ 8.53 (1H, d, J = 1.7 Hz), 8.38 (1H, dd, J
= 8.4, 1.7 Hz), 7.97 (1H, d, J = 8.4 Hz), 5.57 (1H, ddd, J = 9.8, 3.4, 3.3
Hz), 2.50−1.77 (7H, m), 1.25 (3H, s), 1.14 (3H, s), 1.10 (1H, d, J =
10.3 Hz). 13C NMR: δ 162.1, 144.9, 142.5, 135.8, 134.3, 126.1, 125.2,
78.7, 45.1, 40.6, 37.5, 27.4, 26.8, 24.2, 23.0, 22.7. IR νmax: 2919, 1710,
1539, 1367, 1289, 732 cm−1. HRMS (ESI): calcd C16H18N2O6 [M +
Na]+ 357.10571, found [M + Na]+ 357.10595.
α-Nopinyl 2-nitrobenzoate (5g). Following general procedure B,
α-nopinol (5) (0.1 g, 0.71 mmol) in anhydrous DCM (1 mL) and
pyridine was treated with 2-nitrobenzoyl chloride (0.14 g, 0.75 mmol)
for 2 h to afford product 5g as yellow solid (0.18 g, 87%). Mp = 81.0−
81.6 °C. 1H NMR: δ 7.89 (1H, dd, J = 7.8, 1.2 Hz), 7.73 (1H, dd, J =
7.8, 1.8 Hz), 7.66 (1H, dt, J = 1.2 Hz), 7.61 (1H, dt, J = 1.8 Hz), 5.51
(1H, ddd, J = 9.8, 3.5, 3.4 Hz), 2.44−1.80 (7H, m), 1.21 (3H, s), 1.04
(1H, d, J = 10.3 Hz), 0.96 (3H, s). 13C NMR: δ 164.2, 148.0, 132.4,
131.2, 129.4, 127.9, 123.3, 77.7, 44.5, 40.2, 36.9, 27.3, 26.5, 24.0, 21.9,
21.7. IR νmax: 2924, 1721, 1533, 1350, 1290, 736 cm−1. HRMS (ESI):
Calc. C16H19NO4 [M + Na]+ 312.12063, found [M + Na]+ 312.12070.
α-Nopinyl 2,4-Dinitrobenzoate (5h). Following general procedure
B, α-nopinol (5) (0.1 g, 0.71 mmol) in anhydrous Et2O (1 mL) and
pyridine was treated with 2,4-dinitrobenzoyl chloride (0.17 g, 0.75
mmol) for 2 h to afford product 5h as yellow solid (0.20 g, 84%). Mp
= 110.5−112.2 °C. 1H NMR: δ 8.77 (1H, d, J = 2.1 Hz), 8.52 (1H, dd,
J = 8.4, 2.1 Hz), 7.92 (1H, d, J = 8.4 Hz), 5.56 (1H, ddd, J = 10.0, 3.4,
3.3 Hz), 2.48−1.80 (7H, m), 1.22 (3H, s), 1.05 (1H, d, J = 10.5 Hz),
β-Nopinyl 3,5-Dinitrobenzoate (6e). Following general procedure
B, β-nopinol (6) (0.1 g, 0.71 mmol) in anhydrous Et2O (1 mL) and
pyridine was treated with 3,5-dinitrobenzoyl chloride (0.17 g, 0.75
mmol) for 2 h to afford product 6e as a yellow solid (0.20 g, 84%). Mp
= 93.0−94.7 °C. 1H NMR: δ 9.06 (1H, s), 8.98 (2H, s), 5.42 (1H, m),
2.28−1.74 (7H, m), 1.60 (1H, d, J = 8.0 Hz), 1.21 (3H, s), 0.86 (3H,
s). 13C NMR: δ 161.8, 148.3, 134.3, 129.0, 121.8, 76.9, 44.6, 40.0, 39.4,
26.1, 23.0, 22.9, 21.9, 19.8. IR νmax: 2926, 1723, 1543, 1343, 1280, 721
cm−1. HRMS (ESI): calcd C16H18N2O6 [M + Na]+ 357.10571, found
[M + Na]+ 357.10605.
β-Nopinyl 3,4-Dinitrobenzoate (6f). Following general procedure
B, β-nopinol (6) (0.1 g, 0.71 mmol) in anhydrous Et2O (1 mL) and
pyridine was treated with 3,4-dinitrobenzoyl chloride (0.17 g, 0.75
mmol) for 2 h to afford product 6f as yellow solid (0.17 g, 71%). Mp =
1
109.3−111.0 °C. H NMR: δ 8.43 (1H, s), 8.34 (1H, d, J = 8.2 Hz),
7.92 (1H, d, J = 8.2 Hz), 5.41 (1H, m), 2.27−1.74 (7H, m), 1.57 (1H,
d, J = 8.8 Hz), 1.20 (3H, s), 0.85 (3H, s). 13C NMR: δ 162.0, 144.6,
142.2, 135.6, 134.3, 125.8, 125.1, 76.8, 44.6, 40.0, 39.4, 26.1, 23.0, 22.9,
21.9, 19.8. IR νmax: 2913, 1710, 1538, 1366, 1289, 742 cm−1. HRMS
(ESI): calcd C16H18N2O6 [M + Na]+ 357.10571, found [M + Na]+
357.10580.
H
dx.doi.org/10.1021/jo3020243 | J. Org. Chem. XXXX, XXX, XXX−XXX